Skip to main content
Supplement ScienceSupplementScience

Types of Natto / Vitamin K2 (for Arteries): Forms & Bioavailability

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
MK-7 (Menaquinone-7) CapsulesHighBest form for arteries — longest half-life (~72 hours), ensures consistent MGP activation with once-daily dosing
MK-4 (Menaquinone-4) CapsulesLow (short half-life)Bone-focused — requires 3x daily dosing (half-life ~6 hours); less practical for arterial health
Nattokinase Capsules (2000 FU)ModerateBlood flow support — standardized fibrinolytic enzyme units; separate from vitamin K2 content

MK-7 (Menaquinone-7) Capsules

Bioavailability: High. Best for: Best form for arteries — longest half-life (~72 hours), ensures consistent MGP activation with once-daily dosing.

MK-4 (Menaquinone-4) Capsules

Bioavailability: Low (short half-life). Best for: Bone-focused — requires 3x daily dosing (half-life ~6 hours); less practical for arterial health.

Nattokinase Capsules (2000 FU)

Bioavailability: Moderate. Best for: Blood flow support — standardized fibrinolytic enzyme units; separate from vitamin K2 content.

References

  1. RCTKnapen MH, Braam LA, Drummen NE, Bekers O, Hoeks AP, Vermeer C (2015). Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial. Thrombosis and Haemostasis. DOI PubMed
  2. ObservationalGeleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC (2004). Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. Journal of Nutrition. DOI PubMed
  3. RCTKurosawa Y, Nirengi S, Homma T, Esaki K, Ohta M, Clark JF, Hamaoka T (2015). A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. Scientific Reports. DOI PubMed